Torrent Pharma Plans New Investments


The company is also eying the US from its facility in Dahej and the manufacturing facility in Sikkim, India is expected to begin by October 2010.

Sanjay Dalal, chief operating officer of Torrent Pharma, said: "We will invest around Rs 350 crore in the Dahej SEZ and have already started work on land development there.The acquisition process is complete. The facility will take around three to three and a half years to come up."

Torrent Pharma is focused on therapeutic areas of cardiovascular and central nervous system and has achieved significant presence in gastro-intestinal, diabetology, anti-infective and pain management segments.